Niacinamide 4% / Tazarotene 0.05%
Product Images NDC 72934-2160

3 FDA label images from Sincerus Florida, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Niacinamide 4% / Tazarotene 0.05% (NDC 72934-2160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E (2160 2 End)

E (2160 2 End)
A cylindrical white container showing a label with usage directions and contact information. The directions advise applying the product topically as directed by a physician and washing hands after use, with storage instructions at controlled room temperature. The label includes the name Sincerus Florida, LLC with an address in Pompano Beach, FL, and phone numbers for reporting adverse reactions and FDA contact details.*
FDA Label Image

D (2160 2 Front)

D (2160 2 Front)
NIACINAMIDE 4% / TAZAROTENE 0.05% cream in a 30 gm white cylindrical container labeled with the NDC 72934-2160-2. The label shows the product is a compounded drug made by Sincerus Florida, LLC in the USA. The label includes the Sincerus Florida logo with teal and orange colors.*
FDA Label Image

F (2160 2 Middle)

F (2160 2 Middle)
A partial label on a white container for NIACINAMIDE 4% / TAZAROTENE 0.05% cream. The label lists active ingredients Niacinamide USP 4% and Tazarotene 0.05%, and inactive ingredients as Suspenslisse Cream 95.95%. The label also notes Rx only with a lot number and manufacturing and expiration dates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.